Arizona State Retirement System Catalyst Pharmaceuticals, Inc. Transaction History

Arizona State Retirement System

$15.6 Billion
Q3 2024

A detailed history of Arizona State Retirement System transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 30,610 shares of CPRX stock, worth $630,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,610

Previous 29,733 2.95%

Holding current value

$630,566

Previous $460,000 32.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.19 - $21.35 $13,321 - $18,723	877 Added 2.95%	30,610 $608,000
Q2 2024 Aug 05, 2024	BUY	$14.68 - $16.92 $9,600 - $11,065	654 Added 2.25%	29,733 $460,000
Q1 2024 May 07, 2024	BUY	$13.18 - $17.11 $29,826 - $38,719	2,263 Added 8.44%	29,079 $463,000
Q4 2023 Jan 24, 2024	SELL	$11.78 - $17.29 $23,477 - $34,458	-1,993 Reduced 6.92%	26,816 $450,000
Q3 2023 Nov 06, 2023	BUY	$11.69 - $15.02 $7,212 - $9,267	617 Added 2.19%	28,809 $336,000
Q2 2023 Aug 01, 2023	SELL	$11.5 - $18.08 $5,232 - $8,226	-455 Reduced 1.59%	28,192 $378,000
Q1 2023 Apr 27, 2023	BUY	$14.34 - $21.05 $15,558 - $22,839	1,085 Added 3.94%	28,647 $474,000
Q4 2022 Feb 07, 2023	BUY	$12.25 - $19.5 $12,593 - $20,046	1,028 Added 3.87%	27,562 $512,000
Q3 2022 Nov 07, 2022	SELL	$7.06 - $15.52 $98 - $217	-14 Reduced 0.05%	26,534 $340,000
Q2 2022 Jul 28, 2022	BUY	$6.23 - $8.57 $417 - $574	67 Added 0.25%	26,548 $186,000
Q1 2022 May 04, 2022	BUY	$5.31 - $8.31 $801 - $1,254	151 Added 0.57%	26,481 $220,000
Q4 2021 Feb 04, 2022	SELL	$5.21 - $7.45 $2,177 - $3,114	-418 Reduced 1.56%	26,330 $178,000
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $305 - $380	-63 Reduced 0.23%	26,748 $142,000
Q2 2021 Aug 02, 2021	SELL	$4.29 - $6.05 $7,949 - $11,210	-1,853 Reduced 6.46%	26,811 $154,000
Q1 2021 May 06, 2021	BUY	$3.45 - $4.69 $476 - $647	138 Added 0.48%	28,664 $132,000
Q4 2020 Jan 28, 2021	SELL	$2.97 - $3.83 $3,317 - $4,278	-1,117 Reduced 3.77%	28,526 $95,000
Q3 2020 Nov 05, 2020	BUY	$2.97 - $5.08 $22,185 - $37,947	7,470 Added 33.69%	29,643 $88,000
Q2 2020 Aug 04, 2020	BUY	$3.48 - $5.05 $1,392 - $2,020	400 Added 1.84%	22,173 $102,000
Q1 2020 May 05, 2020	BUY	$2.61 - $5.21 $56,827 - $113,437	21,773 New	21,773 $84,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Catalyst Pharmaceuticals, Inc. Transaction History